Evgen Pharma

Clinical-stage drug development company, Evgen Pharma, has been granted a key European patent ascribing intellectual property rights to the company for a method of stabilising sulforaphane, which is the basis of its lead product, SFX-01 Read more


Evgen Pharma, a clinical-stage drug development company, has announced its collaboration with King’s College London to advance its lead product candidate as a therapy for ischaemic stroke. Read more